Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Colorcon
Moodys
Harvard Business School
Medtronic

Last Updated: September 26, 2022

DIETHYLSTILBESTROL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Diethylstilbestrol, and when can generic versions of Diethylstilbestrol launch?

Diethylstilbestrol is a drug marketed by Lilly and is included in three NDAs.

The generic ingredient in DIETHYLSTILBESTROL is diethylstilbestrol. There are twenty-six drug master file entries for this compound. Additional details are available on the diethylstilbestrol profile page.

Drug patent expirations by year for DIETHYLSTILBESTROL
Recent Clinical Trials for DIETHYLSTILBESTROL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of South AlabamaN/A
Elysium Health, Inc.N/A
Janssen Research & Development, LLCPhase 2

See all DIETHYLSTILBESTROL clinical trials

Medical Subject Heading (MeSH) Categories for DIETHYLSTILBESTROL

US Patents and Regulatory Information for DIETHYLSTILBESTROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly DIETHYLSTILBESTROL diethylstilbestrol SUPPOSITORY;VAGINAL 004040-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Lilly DIETHYLSTILBESTROL diethylstilbestrol TABLET, DELAYED RELEASE;ORAL 004039-006 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Lilly DIETHYLSTILBESTROL diethylstilbestrol TABLET, DELAYED RELEASE;ORAL 004039-005 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Lilly DIETHYLSTILBESTROL diethylstilbestrol TABLET;ORAL 004041-002 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Lilly DIETHYLSTILBESTROL diethylstilbestrol SUPPOSITORY;VAGINAL 004040-002 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Lilly DIETHYLSTILBESTROL diethylstilbestrol TABLET, DELAYED RELEASE;ORAL 004039-002 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Lilly DIETHYLSTILBESTROL diethylstilbestrol TABLET, DELAYED RELEASE;ORAL 004039-004 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Medtronic
McKinsey
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.